Questions About Cancer? 1-800-4-CANCER
  • Print
  • Facebook
  • Twitter
  • Google+
  • Pinterest

NCI Drug Dictionary


von Hippel-Lindau peptide vaccine 
A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms:VHL peptide vaccine
VHL Peptides